STI update: Testing, treatment, and emerging threats

Cleve Clin J Med. 2019 Nov;86(11):733-740. doi: 10.3949/ccjm.86a.18098.

Abstract

Fast, sensitive molecular diagnostic tests that use urine or self-collected swabs may lead to more screening opportunities and be more acceptable to patients, resulting in faster and more accurate diagnosis and treatment of gonorrhea, chlamydia, trichomoniasis, and Mycoplasma genitalium infection.

Publication types

  • Review

MeSH terms

  • Chlamydia Infections / diagnosis
  • Chlamydia Infections / prevention & control
  • Chlamydia Infections / therapy
  • Communicable Diseases, Emerging / diagnosis
  • Communicable Diseases, Emerging / prevention & control
  • Communicable Diseases, Emerging / therapy
  • Female
  • Gonorrhea / diagnosis
  • Gonorrhea / prevention & control
  • Gonorrhea / therapy
  • Humans
  • Male
  • Mycoplasma Infections / diagnosis
  • Mycoplasma Infections / prevention & control
  • Mycoplasma Infections / therapy
  • Mycoplasma genitalium
  • Sexually Transmitted Diseases / diagnosis*
  • Sexually Transmitted Diseases / prevention & control
  • Sexually Transmitted Diseases / therapy
  • Trichomonas Vaginitis / diagnosis
  • Trichomonas Vaginitis / prevention & control
  • Trichomonas Vaginitis / therapy